Skip to main content
Top
Published in: Current Gastroenterology Reports 6/2011

01-12-2011 | Stomach and Duodenum (Joseph R. Pisegna, Section Editor)

Ménétrier’s Disease of the Stomach: A Clinical Challenge

Author: Nils W. G. Lambrecht

Published in: Current Gastroenterology Reports | Issue 6/2011

Login to get access

Abstract

Ménétrier’s disease is a rare hyperproliferative protein-losing gastropathy of the gastric foveolar epithelium. Most common symptoms include epigastric pain with fullness and vomiting, and generalized peripheral edema with hypoalbuminemia. Radiologically, the wall of the gastric body and fundus is diffusely thickened, often with antral sparing. Giant rugal edematous folds are seen on gastroscopy, and histology of biopsy material shows diffuse foveolar hyperplasia with cystic dilatation of the glandular portion of the gastric mucosa in the absence of significant inflammatory infiltrate. The recent discovery of transforming growth factor α overexpression opens the way of epidermal growth factor receptor blockade with cetuximab as first-line treatment modality in severe cases of Ménétrier’s disease.
Literature
1.
go back to reference Bayerdorffer E, Ritter MM, Hatz R, et al. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori–is Helicobacter pylori a pathogenic factor in Menetrier’s disease? Gut. 1994;35:701–4.PubMedCrossRef Bayerdorffer E, Ritter MM, Hatz R, et al. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori–is Helicobacter pylori a pathogenic factor in Menetrier’s disease? Gut. 1994;35:701–4.PubMedCrossRef
2.
go back to reference Beauchamp RD, Barnard JA, McCutchen CM, et al. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest. 1989;84:1017–23.PubMedCrossRef Beauchamp RD, Barnard JA, McCutchen CM, et al. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest. 1989;84:1017–23.PubMedCrossRef
3.
go back to reference Blackstone MM, Mittal MK. The edematous toddler: a case of pediatric Menetrier disease. Pediatr Emerg Care. 2008;24:682–4.PubMedCrossRef Blackstone MM, Mittal MK. The edematous toddler: a case of pediatric Menetrier disease. Pediatr Emerg Care. 2008;24:682–4.PubMedCrossRef
4.
go back to reference Celikel C, Eren F, Gulluoglu B, et al. Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications. Pathol Oncol Res. 2007;13:215–26.PubMedCrossRef Celikel C, Eren F, Gulluoglu B, et al. Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications. Pathol Oncol Res. 2007;13:215–26.PubMedCrossRef
5.
go back to reference Coffey RJ, Washington MK, Corless CL, Heinrich MC. Menetrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest. 2007;117:70–80.PubMedCrossRef Coffey RJ, Washington MK, Corless CL, Heinrich MC. Menetrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest. 2007;117:70–80.PubMedCrossRef
6.
go back to reference Crampton JR, Hunter JO, Neale G, Wight DG. Chronic lymphocytic gastritis and protein losing gastropathy. Gut. 1989;30 Spec No:71-74. Crampton JR, Hunter JO, Neale G, Wight DG. Chronic lymphocytic gastritis and protein losing gastropathy. Gut. 1989;30 Spec No:71-74.
7.
go back to reference • Dempsey PJ, Goldenring JR, Soroka CJ, et al. Possible role of transforming growth factor alpha in the pathogenesis of Menetrier’s disease: supportive evidence form humans and transgenic mice. Gastroenterology. 1992;103:1950–63. This landmark paper represents the start of a new era in the pathophysiology of MD indicating for the first time the link between gastric mucosal TGFα overexpression with increased EGFR signaling and hyperplastic foveolar epithelium in patients with MD. PubMed • Dempsey PJ, Goldenring JR, Soroka CJ, et al. Possible role of transforming growth factor alpha in the pathogenesis of Menetrier’s disease: supportive evidence form humans and transgenic mice. Gastroenterology. 1992;103:1950–63. This landmark paper represents the start of a new era in the pathophysiology of MD indicating for the first time the link between gastric mucosal TGFα overexpression with increased EGFR signaling and hyperplastic foveolar epithelium in patients with MD. PubMed
8.
go back to reference Elinav E, Korem M, Ofran Y, et al. Hyperplastic gastropathy as a presenting manifestation of systemic lupus erythematosus. Lupus. 2004;13:60–3.PubMedCrossRef Elinav E, Korem M, Ofran Y, et al. Hyperplastic gastropathy as a presenting manifestation of systemic lupus erythematosus. Lupus. 2004;13:60–3.PubMedCrossRef
9.
go back to reference • Fiske WH, Tanksley J, Nam KT, et al. Efficacy of cetuximab in the treatment of Menetrier’s disease. Sci Transl. Med 2009;1:8ra18. This paper reports promising data of the first trial of treatment with a high-affinity EGF receptor blocking antibody(cetuximab) indicating the use of this novel biological agent as first-line therapy in severe protein-losing MD.PubMedCrossRef • Fiske WH, Tanksley J, Nam KT, et al. Efficacy of cetuximab in the treatment of Menetrier’s disease. Sci Transl. Med 2009;1:8ra18. This paper reports promising data of the first trial of treatment with a high-affinity EGF receptor blocking antibody(cetuximab) indicating the use of this novel biological agent as first-line therapy in severe protein-losing MD.PubMedCrossRef
10.
11.
go back to reference Goebel M, Stengel A, Lambrecht NW, Sachs G. Selective gene expression by rat gastric corpus epithelium. Physiol Genomics. 43:237–54 Goebel M, Stengel A, Lambrecht NW, Sachs G. Selective gene expression by rat gastric corpus epithelium. Physiol Genomics. 43:237–54
12.
go back to reference Hsu CT, Ito M, Kawase Y, et al. Early gastric cancer arising from localized Menetrier’s disease. Gastroenterol Jpn. 1991;26:213–7.PubMed Hsu CT, Ito M, Kawase Y, et al. Early gastric cancer arising from localized Menetrier’s disease. Gastroenterol Jpn. 1991;26:213–7.PubMed
13.
go back to reference Kim J, Cheong JH, Chen J, et al. Menetrier’s disease in korea: report of two cases and review of cases in a gastric cancer prevalent region. Yonsei Med J. 2004;45:555–60.PubMed Kim J, Cheong JH, Chen J, et al. Menetrier’s disease in korea: report of two cases and review of cases in a gastric cancer prevalent region. Yonsei Med J. 2004;45:555–60.PubMed
14.
go back to reference Kovacs AA, Churchill MA, Wood D, et al. Molecular and epidemiologic evaluations of a cluster of cases of Menetrier’s disease associated with cytomegalovirus. Pediatr Infect Dis J. 1993;12:1011–4.PubMedCrossRef Kovacs AA, Churchill MA, Wood D, et al. Molecular and epidemiologic evaluations of a cluster of cases of Menetrier’s disease associated with cytomegalovirus. Pediatr Infect Dis J. 1993;12:1011–4.PubMedCrossRef
15.
go back to reference Lam SK, Hui WK, Ho J, et al. Pachydermoperiostosis, hypertrophic gastropathy, and peptic ulcer. Gastroenterology. 1983;84:834–9.PubMed Lam SK, Hui WK, Ho J, et al. Pachydermoperiostosis, hypertrophic gastropathy, and peptic ulcer. Gastroenterology. 1983;84:834–9.PubMed
16.
go back to reference Larsen B, Tarp U, Kristensen E. Familial giant hypertrophic gastritis (Menetrier’s disease). Gut. 1987;28:1517–21.PubMedCrossRef Larsen B, Tarp U, Kristensen E. Familial giant hypertrophic gastritis (Menetrier’s disease). Gut. 1987;28:1517–21.PubMedCrossRef
17.
go back to reference Lechago J, Genta RM. Stomach and duodenum. In: Damjanov I, Linder J, editors. Anderson’s pathology. New York: Mosby; 1996. 1684. Lechago J, Genta RM. Stomach and duodenum. In: Damjanov I, Linder J, editors. Anderson’s pathology. New York: Mosby; 1996. 1684.
18.
go back to reference Lewis JJ, Goldenring JR, Modlin IM, Coffey RJ. Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism. Surgery. 1990;108:220–6. discussion 226–227.PubMed Lewis JJ, Goldenring JR, Modlin IM, Coffey RJ. Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism. Surgery. 1990;108:220–6. discussion 226–227.PubMed
19.
go back to reference Maffei M, Piessevaux H, Jouret-Mourin A. Polypoid lesions in the stomach and proximal esophagus. Menetrier’s disease of the stomach. Gastroenterology. 140:32, 369. Maffei M, Piessevaux H, Jouret-Mourin A. Polypoid lesions in the stomach and proximal esophagus. Menetrier’s disease of the stomach. Gastroenterology. 140:32, 369.
20.
go back to reference Ménétrier P. Des polyadenomes gastriques et leur rapport avec le cancer de l’estomac. Arch Physiol Norm Pathol. 1888;1:236–62. Ménétrier P. Des polyadenomes gastriques et leur rapport avec le cancer de l’estomac. Arch Physiol Norm Pathol. 1888;1:236–62.
21.
go back to reference Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Menetrier Study Group. Scand J Gastroenterol Suppl. 1992;194:1–7.PubMedCrossRef Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Menetrier Study Group. Scand J Gastroenterol Suppl. 1992;194:1–7.PubMedCrossRef
22.
go back to reference Meyer J. Polyposis gastrica (Polyadenomata). JAMA. 1960;1913:61. Meyer J. Polyposis gastrica (Polyadenomata). JAMA. 1960;1913:61.
23.
go back to reference Moon SY, Kim KO, Park SH, et al. [Gastritis cystica profunda accompanied by multiple early gastric cancers]. Korean J Gastroenterol. 55:325–30. Moon SY, Kim KO, Park SH, et al. [Gastritis cystica profunda accompanied by multiple early gastric cancers]. Korean J Gastroenterol. 55:325–30.
24.
go back to reference Nguyen VX, Nguyen CC, Leighton JA, et al. The association of Menetrier disease with ulcerative colitis: a case report with implications on the pathogenesis of Menetrier disease. Case Rep Gastroenterol. 4:66–70. Nguyen VX, Nguyen CC, Leighton JA, et al. The association of Menetrier disease with ulcerative colitis: a case report with implications on the pathogenesis of Menetrier disease. Case Rep Gastroenterol. 4:66–70.
25.
go back to reference Oguri A, Ohmiya N, Taguchi A, et al. Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes. Eur J Gastroenterol Hepatol. 2007;19:561–6.PubMedCrossRef Oguri A, Ohmiya N, Taguchi A, et al. Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes. Eur J Gastroenterol Hepatol. 2007;19:561–6.PubMedCrossRef
26.
go back to reference Ohyama I, Ohmiya N, Niwa Y, et al. The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur J Gastroenterol Hepatol. 2004;16:693–700.PubMedCrossRef Ohyama I, Ohmiya N, Niwa Y, et al. The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur J Gastroenterol Hepatol. 2004;16:693–700.PubMedCrossRef
27.
go back to reference Rhodes JA, Tam JP, Finke U, et al. Transforming growth factor alpha inhibits secretion of gastric acid. Proc Natl Acad Sci U S A. 1986;83:3844–6.PubMedCrossRef Rhodes JA, Tam JP, Finke U, et al. Transforming growth factor alpha inhibits secretion of gastric acid. Proc Natl Acad Sci U S A. 1986;83:3844–6.PubMedCrossRef
28.
go back to reference Rich A, Toro TZ, Tanksley J, et al. Distinguishing Menetrier’s disease from its mimics. Gut. 2010;59:1617–24.PubMedCrossRef Rich A, Toro TZ, Tanksley J, et al. Distinguishing Menetrier’s disease from its mimics. Gut. 2010;59:1617–24.PubMedCrossRef
29.
go back to reference Romano M, Polk WH, Awad JA, et al. Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest. 1992;90:2409–21.PubMedCrossRef Romano M, Polk WH, Awad JA, et al. Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest. 1992;90:2409–21.PubMedCrossRef
30.
go back to reference Saadia B, Salna BH, Mohamed J, et al. Menetrier’s disease and gastric carcinoma. Tunis Med. 2005;83:499–502.PubMed Saadia B, Salna BH, Mohamed J, et al. Menetrier’s disease and gastric carcinoma. Tunis Med. 2005;83:499–502.PubMed
31.
go back to reference Scharschmidt BF. The natural history of hypertrophic gastrophy (Menetrier’s disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med. 1977;63:644–52.PubMedCrossRef Scharschmidt BF. The natural history of hypertrophic gastrophy (Menetrier’s disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med. 1977;63:644–52.PubMedCrossRef
32.
go back to reference earcy RM, Malagelada JR. Menetrier’s disease and idiopathic hypertrophic gastropathy. Ann Intern Med. 1984;100:565–70.PubMed earcy RM, Malagelada JR. Menetrier’s disease and idiopathic hypertrophic gastropathy. Ann Intern Med. 1984;100:565–70.PubMed
33.
go back to reference Takagi H, Jhappan C, Sharp R, Merlino G. Hypertrophic gastropathy resembling Menetrier’s disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest. 1992;90:1161–7.PubMedCrossRef Takagi H, Jhappan C, Sharp R, Merlino G. Hypertrophic gastropathy resembling Menetrier’s disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest. 1992;90:1161–7.PubMedCrossRef
34.
go back to reference Tsuji T, Iwahashi M, Nakamori M, et al. Multiple early gastric cancer with gastritis cystica profunda showing various histological types. Hepatogastroenterology. 2008;55:1150–2.PubMed Tsuji T, Iwahashi M, Nakamori M, et al. Multiple early gastric cancer with gastritis cystica profunda showing various histological types. Hepatogastroenterology. 2008;55:1150–2.PubMed
35.
go back to reference Turner JR, Odze RD. Polyps of the stomach. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. New York: Saunders; 2004. p. 274–5. Turner JR, Odze RD. Polyps of the stomach. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. New York: Saunders; 2004. p. 274–5.
36.
go back to reference Wood MG, Bates C, Brown RC, Losowsky MS. Intramucosal carcinoma of the gastric antrum complicating Menetrier’s disease. J Clin Pathol. 1983;36:1071–5.PubMedCrossRef Wood MG, Bates C, Brown RC, Losowsky MS. Intramucosal carcinoma of the gastric antrum complicating Menetrier’s disease. J Clin Pathol. 1983;36:1071–5.PubMedCrossRef
Metadata
Title
Ménétrier’s Disease of the Stomach: A Clinical Challenge
Author
Nils W. G. Lambrecht
Publication date
01-12-2011
Publisher
Current Science Inc.
Published in
Current Gastroenterology Reports / Issue 6/2011
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-011-0222-8

Other articles of this Issue 6/2011

Current Gastroenterology Reports 6/2011 Go to the issue

Stomach and Duodenum (Joseph R. Pisegna, Section Editor)

Gastric Infection by Helicobacter pylori

Stomach and Duodenum (Joseph R. Pisegna, Section Editor)

Update on the Endoscopic Management of Peptic Ulcer Bleeding

Stomach and Duodenum (Joseph R. Pisegna, Section Editor)

Diagnosis and Management of Pernicious Anemia

Stomach and Duodenum (Joseph R. Pisegna, Section Editor)

Endoscopic Management of Gastrointestinal Stromal Tumors

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.